# Potassium Channel Activators


Potassium channel activators stimulate ATP sensitive K^+^ channels, causing an increase in intracellular cGMP and subsequent relaxation of smooth muscle in the:

* Heart
* Venous capacitance vessels
* Arterioles

|Property|Nicorandil
|--|--|
|**Uses**|HTN, angina, CHF
|**Route of Administration**|PO
|**Dosing**|10-30mg BD
|**Absorption**|80% PO bioavailability
|**Distribution**|Negligible protein binding
|**Metabolism**|Hepatic denitration
|**Elimination**|Renal elimination of active drug and metabolites
|**CVS**|↓ Preload, ↓ afterload, ↓ BP, ↑ coronary flow
|**CNS**|Headache, improves with ongoing use
|**Haeme**|Inhibition of platelet aggregation

---
## References

1. Peck TE, Hill SA. Pharmacology for Anaesthesia and Intensive Care. 4th Ed. Cambridge University Press. 2014.\
